{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:20Z","timestamp":1787020280143,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polypharmacy increases the risk of potential drug\u2013drug interactions (pDDIs). This retrospective analysis was conducted to detect pDDIs and adverse drug reactions (ADRs) among older adults with psychiatric disorder, and identify pDDIs with clinical significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was carried out based on the medical records of older adults with psychiatric disorders. Data on demographic characteristics, substance abuse, medical history, and medications were extracted. The Lexi-Interact online database was used to detect pDDIs. The minimal clinically important difference (MCID) was set as the change in the Treatment Emergent Symptom Scale (TESS) score between admission and discharge. The median and interquartile ranges were used for continuous variables, and frequencies were calculated for dichotomous variables. Poisson regression was implemented to determine the factors influencing the number of ADR types. The influencing factors of each ADR and the clinical significance of the severity of the ADR were analysed using binary logistic regression.\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 308 older adults were enrolled, 171 (55.52%) of whom had at least 1 pDDI. Thirty-six types of pDDIs that should be avoided were found, and the most frequent pDDI was the coadministration of lorazepam and olanzapine (55.5%). A total of 26 ADRs induced by pDDIs were identified, and the most common ADR was constipation (26.05%). There was a 9.4 and 10.3% increase in the number of ADR types for each extra medical diagnosis and for each extra drug, respectively. There was a 120% increase in the number of ADR types for older adults hospitalized for 18\u201328\u2009days compared with those hospitalized for 3\u201317\u2009days. There was an 11.1% decrease in the number of ADR types for each extra readmission. The length of hospitalization was a risk factor for abnormal liver function (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The use of a large number of drugs was a risk factor for gastric distress (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) and dizziness and fainting (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). None of the four pDDIs, including coadministrations of olanzapine and lorazepam, quetiapine and potassium chloride, quetiapine and escitalopram, and olanzapine and clonazepam, showed clinical significance of ADR severity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>pDDIs are prevalent in older adults, and the rate is increasing. However, many pDDIs may have no clinical significance in terms of ADR severity. Further research on assessing pDDIs, and possible measures to prevent serious ADRs induced by DDIs is needed to reduce the clinical significance of pDDIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-022-04207-4","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T04:03:59Z","timestamp":1661141039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical significance of potential drug\u2013drug interactions in older adults with psychiatric disorders: a retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianchi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"issue":"9","key":"4207_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/070674370705200906","volume":"52","author":"PJ Martens","year":"2007","unstructured":"Martens PJ, Fransoo R, Burland E, et al. Prevalence of mental illness and its impact on the use of home care and nursing homes: a population-based study of older adults in Manitoba. Can J Psychiatry. 2007;52(9):581\u201390. https:\/\/doi.org\/10.1177\/070674370705200906.","journal-title":"Can J Psychiatry"},{"issue":"1","key":"4207_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/ACO.0000000000000814","volume":"33","author":"PA Th\u00fcrmann","year":"2020","unstructured":"Th\u00fcrmann PA. Pharmacodynamics and pharmacokinetics in older adults. Curr Opin Anaesthesiol. 2020;33(1):109\u201313. https:\/\/doi.org\/10.1097\/ACO.0000000000000814.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"2","key":"4207_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/inm.12547","volume":"28","author":"N Houben","year":"2019","unstructured":"Houben N, Janssen E, Hendriks MRC, et al. Physical health status of older adults with severe mental illness: the PHiSMI-E cohort study. Int J Ment Health Nurs. 2019;28(2):457\u201367. https:\/\/doi.org\/10.1111\/inm.12547.","journal-title":"Int J Ment Health Nurs"},{"issue":"3","key":"4207_CR4","doi-asserted-by":"publisher","first-page":"e010989","DOI":"10.1136\/bmjopen-2015-010989","volume":"6","author":"SS Mortazavi","year":"2016","unstructured":"Mortazavi SS, Shati M, Keshtkar A, et al. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open. 2016;6(3):e010989. https:\/\/doi.org\/10.1136\/bmjopen-2015-010989.","journal-title":"BMJ Open"},{"issue":"1","key":"4207_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12877-021-02247-1","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li X, Jia D, et al. Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study. BMC Geriatr. 2021;21(1):308. https:\/\/doi.org\/10.1186\/s12877-021-02247-1.","journal-title":"BMC Geriatr"},{"key":"4207_CR6","doi-asserted-by":"publisher","first-page":"686990","DOI":"10.3389\/fphar.2021.686990","volume":"12","author":"J Schneider","year":"2021","unstructured":"Schneider J, Algharably EAE, Budnick A, et al. High prevalence of multimorbidity and polypharmacy in elderly patients with chronic pain receiving home care are associated with multiple medication-related problems. Front Pharmacol. 2021;12:686990. https:\/\/doi.org\/10.3389\/fphar.2021.686990.","journal-title":"Front Pharmacol"},{"issue":"7\u20138","key":"4207_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/jocn.15595","volume":"30","author":"HF Hsu","year":"2021","unstructured":"Hsu HF, Chen KM, Belcastro F, et al. Polypharmacy and pattern of medication use in community-dwelling older adults: a systematic review. J Clin Nurs. 2021;30(7\u20138):918\u201328. https:\/\/doi.org\/10.1111\/jocn.15595.","journal-title":"J Clin Nurs"},{"issue":"3","key":"4207_CR8","doi-asserted-by":"publisher","first-page":"e0214240","DOI":"10.1371\/journal.pone.0214240","volume":"14","author":"MP Oktora","year":"2019","unstructured":"Oktora MP, Denig P, Bos JHJ, et al. Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PLoS One. 2019;14(3):e0214240. https:\/\/doi.org\/10.1371\/journal.pone.0214240.","journal-title":"PLoS One"},{"issue":"12","key":"4207_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson JW, Morin L, Tan ECK, et al. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185\u201396. https:\/\/doi.org\/10.1080\/14740338.2018.1546841.","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"4207_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","volume":"74","author":"FR Motter","year":"2018","unstructured":"Motter FR, Fritzen JS, Hilmer SN, et al. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74(6):679\u2013700. https:\/\/doi.org\/10.1007\/s00228-018-2446-0.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"4207_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00213-020-05716-4","volume":"238","author":"BO Plasencia-Garc\u00eda","year":"2021","unstructured":"Plasencia-Garc\u00eda BO, Rodr\u00edguez-Men\u00e9ndez G, Rico-Rangel MI, et al. Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review. Psychopharmacology. 2021;238(2):329\u201340. https:\/\/doi.org\/10.1007\/s00213-020-05716-4.","journal-title":"Psychopharmacology"},{"issue":"D1","key":"4207_CR12","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382. https:\/\/doi.org\/10.1093\/nar\/gkx1037.","journal-title":"Nucleic Acids Res"},{"key":"4207_CR13","doi-asserted-by":"publisher","first-page":"624562","DOI":"10.3389\/fphar.2020.624562","volume":"11","author":"L L\u00e9tinier","year":"2020","unstructured":"L\u00e9tinier L, Ferreira A, Marceron A, et al. Spontaneous reports of serious adverse drug reactions resulting from drug-drug interactions: an analysis from the French pharmacovigilance database. Front Pharmacol. 2020;11:624562. https:\/\/doi.org\/10.3389\/fphar.2020.624562.","journal-title":"Front Pharmacol"},{"issue":"9237","key":"4207_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/s0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(00)02799-9.","journal-title":"Lancet"},{"issue":"1","key":"4207_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/a-1492-3293","volume":"55","author":"BO Plasencia-Garcia","year":"2022","unstructured":"Plasencia-Garcia BO, Rico-Rangel MI, Rodriguez-Menendez G, et al. Drug-drug interactions between COVID-19 treatments and antidepressants, mood stabilizers\/anticonvulsants, and benzodiazepines: integrated evidence from 3 databases. Pharmacopsychiatry. 2022;55(1):40\u20137. https:\/\/doi.org\/10.1055\/a-1492-3293.","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"4207_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jcpt.13058","volume":"45","author":"C Palleria","year":"2020","unstructured":"Palleria C, Roberti R, Iannone LF, et al. Clinically relevant drug interactions between statins and antidepressants. J Clin Pharm Ther. 2020;45(2):227\u201339. https:\/\/doi.org\/10.1111\/jcpt.13058.","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"4207_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2519\/jospt.2019.0704","volume":"49","author":"SJ Kamper","year":"2019","unstructured":"Kamper SJ. Interpreting outcomes 2-statistical significance and clinical meaningfulness: linking evidence to practice. J Orthop Sports Phys Ther. 2019;49(7):559\u201360. https:\/\/doi.org\/10.2519\/jospt.2019.0704.","journal-title":"J Orthop Sports Phys Ther"},{"key":"4207_CR18","doi-asserted-by":"publisher","unstructured":"Harris JE, Zoellner J. Pointers and pitfalls in interpreting nutrition and dietetics research: the importance of statistical and clinical significance. J Acad Nutr Diet. 2021. https:\/\/doi.org\/10.1016\/j.jand.2021.10.022.","DOI":"10.1016\/j.jand.2021.10.022"},{"issue":"2","key":"4207_CR19","doi-asserted-by":"publisher","first-page":"e000011","DOI":"10.1136\/gpsych-2018-000011","volume":"31","author":"Y Gu","year":"2018","unstructured":"Gu Y, Peng H, Dai J, et al. Evaluation of paliperidone on social function in patients with chronic schizophrenia. Gen Psychiatr. 2018;31(2):e000011. https:\/\/doi.org\/10.1136\/gpsych-2018-000011.","journal-title":"Gen Psychiatr"},{"issue":"2","key":"4207_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cct.2013.11.015","volume":"37","author":"GH Pelton","year":"2014","unstructured":"Pelton GH, Andrews H, Roose SP, et al. Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design. Contemp Clin Trials. 2014;37(2):200\u20138. https:\/\/doi.org\/10.1016\/j.cct.2013.11.015.","journal-title":"Contemp Clin Trials"},{"key":"4207_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijnurstu.2017.05.002","volume":"73","author":"DF Polit","year":"2017","unstructured":"Polit DF. Clinical significance in nursing research: a discussion and descriptive analysis. Int J Nurs Stud. 2017;73:17\u201323. https:\/\/doi.org\/10.1016\/j.ijnurstu.2017.05.002.","journal-title":"Int J Nurs Stud"},{"issue":"4","key":"4207_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13651501.2016.1213854","volume":"20","author":"MC Ocana-Zurita","year":"2016","unstructured":"Ocana-Zurita MC, Juarez-Rojop IE, Genis A, et al. Potential drug-drug interaction in Mexican patients with schizophrenia. Int J Psychiatry Clin Pract. 2016;20(4):249\u201353. https:\/\/doi.org\/10.1080\/13651501.2016.1213854.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"7","key":"4207_CR23","doi-asserted-by":"publisher","first-page":"e0236830","DOI":"10.1371\/journal.pone.0236830","volume":"15","author":"S Ruangritchankul","year":"2020","unstructured":"Ruangritchankul S, Peel NM, Hanjani LS, et al. Drug related problems in older adults living with dementia. PLoS One. 2020;15(7):e0236830. https:\/\/doi.org\/10.1371\/journal.pone.0236830.","journal-title":"PLoS One"},{"issue":"7","key":"4207_CR24","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1111\/bcp.14671","volume":"87","author":"FM de Vries","year":"2021","unstructured":"de Vries FM, Stingl JC, Breteler MMB. Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland study. Br J Clin Pharmacol. 2021;87(7):2732\u201356. https:\/\/doi.org\/10.1111\/bcp.14671.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"4207_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s41999-018-0030-x","volume":"9","author":"D O'Mahony","year":"2018","unstructured":"O'Mahony D, O'Connor MN, Eustace J, et al. The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients. Eur Geriatr Med. 2018;9(2):191\u20139. https:\/\/doi.org\/10.1007\/s41999-018-0030-x.","journal-title":"Eur Geriatr Med"},{"key":"4207_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejrad.2017.01.015","volume":"89","author":"H Lee","year":"2017","unstructured":"Lee H, Song S, Oh YK, et al. Is gender still a predisposing factor in contrast-media associated adverse drug reactions? A systematic review and meta-analysis of randomized trials and observational studies. Eur J Radiol. 2017;89:81\u20139. https:\/\/doi.org\/10.1016\/j.ejrad.2017.01.015.","journal-title":"Eur J Radiol"},{"issue":"4","key":"4207_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/cpt.1866","volume":"108","author":"J Sun","year":"2020","unstructured":"Sun J, Deng X, Chen X, et al. Incidence of adverse drug reactions in COVID-19 patients in China: an active monitoring study by hospital pharmacovigilance system. Clin Pharmacol Ther. 2020;108(4):791\u20137. https:\/\/doi.org\/10.1002\/cpt.1866.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"4207_CR28","doi-asserted-by":"publisher","first-page":"e968","DOI":"10.1634\/theoncologist.2018-0476","volume":"24","author":"AH Lavan","year":"2019","unstructured":"Lavan AH, O'Mahony D, Buckley M, et al. Adverse drug reactions in an oncological population: prevalence, predictability, and preventability. Oncologist. 2019;24(9):e968\u201377. https:\/\/doi.org\/10.1634\/theoncologist.2018-0476.","journal-title":"Oncologist"},{"issue":"1","key":"4207_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/a:1009018809174","volume":"12","author":"S Madhusoodanan","year":"2000","unstructured":"Madhusoodanan S, Brenner R, Suresh P, et al. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study. Ann Clin Psychiatry. 2000;12(1):11\u20138. https:\/\/doi.org\/10.1023\/a:1009018809174.","journal-title":"Ann Clin Psychiatry"},{"issue":"2","key":"4207_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-2004-815527","volume":"37","author":"N Bergemann","year":"2004","unstructured":"Bergemann N, Frick A, Parzer P, et al. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. Pharmacopsychiatry. 2004;37(2):63\u20138. https:\/\/doi.org\/10.1055\/s-2004-815527.","journal-title":"Pharmacopsychiatry."},{"issue":"12","key":"4207_CR31","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.4088\/jcp.v66n1219c","volume":"66","author":"JL Zacher","year":"2005","unstructured":"Zacher JL, Roche-Desilets J. Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam. J Clin Psychiatry. 2005;66(12):1614\u20135. https:\/\/doi.org\/10.4088\/jcp.v66n1219c.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4207_CR32","doi-asserted-by":"publisher","first-page":"e23378","DOI":"10.7759\/cureus.23378","volume":"14","author":"RK Tripathi","year":"2022","unstructured":"Tripathi RK, Gajbhiye S, Jalgaonkar S, et al. Antipsychotic drug utilization and adverse drug reaction profiling in patients with schizophrenia at a tertiary Care Hospital in Western India. Cureus. 2022;14(3):e23378. https:\/\/doi.org\/10.7759\/cureus.23378.","journal-title":"Cureus"},{"key":"4207_CR33","doi-asserted-by":"publisher","unstructured":"Tissot M, Valnet-Rabier MB, Stalder T, et al. Epidemiology and economic burden of \"serious\" adverse drug reactions: real-world evidence research based on pharmacovigilance data. Therapie. 2021. https:\/\/doi.org\/10.1016\/j.therap.2021.12.007.","DOI":"10.1016\/j.therap.2021.12.007"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04207-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T04:04:33Z","timestamp":1661141073000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04207-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4207"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04207-4","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Clinical Research Ethics Committee of the Fourth People\u2019s hospital of Lianyungang (2021LSYYXLL-P15) and it has been performed in accordance with WMA declaration of Helsinki -ethical principles for medical research involving human subjects. As the study is a retrospective study not involving human embryos, gametes, stem cells, animals, palaeontological and geological material or plants, Lianyungang Fourth People\u2019s Hospital Medical Ethics Committee waived the need for informed consent. The reasons are following. First, patients\u2019 names were not listed in this study and the hospitalization numbers were used as the identity when collecting data, which were omitted in the subsequent analyses. Patients\u2019 privacy will not be exposed. Next, no biological specimens were collected from patients in this study. Test results of patients at specific time points were recorded retrospectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"563"}}